Pharmacogenomics and Opioid Analgesics: Clinical Implications
Variation exists in patient response on analgesic treatment in terms of efficacy and safety. This variation may be in part explained by pharmacogenomics. This paper aimed to review data on pharmacogenomics of opioid analgesics focusing on the effect of genetic variation on the efficacy and safety of...
Main Author: | Eugenia Yiannakopoulou |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | International Journal of Genomics |
Online Access: | http://dx.doi.org/10.1155/2015/368979 |
Similar Items
-
Pharmacogenomic considerations in opioid analgesia
by: Vuilleumier PH, et al.
Published: (2012-08-01) -
A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.
by: Clint Mizzi, et al.
Published: (2016-01-01) -
Clinically important drug interactions with opioid and non-opioid analgesics
by: Vezmar-Kovačević Sandra, et al.
Published: (2019-01-01) -
Clinically important drug interactions with opioid and non-opioid analgesics
by: Vezmar-Kovačević Sandra, et al.
Published: (2018-01-01) -
Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.
by: Clint Mizzi, et al.
Published: (2017-01-01)